Potential pharmacological approach in the regulation of angiotensin-II conversion enzyme and dipeptidyl-peptidase 4 in diabetic COVID-19 patients
Accepted: 3 December 2020
HTML: 13
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The global pandemic caused by coronavirus disease 2019 (COVID-19) has caused more than 1 million deaths worldwide. Some vaccines in clinical trials have reached stage 3. In the meantime, the understanding of biological and pathophysiological mechanisms of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection is still unclear, such as the role that angiotensin-II conversion enzyme (ACE-2) and dipeptidyl-peptidase 4 (DPP-IV) may play in patients with diabetes related to COVID-19. The individual with diabetes is a known COVID-19 risk patient. Probably, the pharmacological regulation of the angiotensin renin system and ACE-2 on the one hand, and of the incretin system and DPP-IV on the other hand, could represent a therapeutic route of fundamental importance to reduce the risk of SARS-CoV-2 infection or of severe complications caused by infection.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
-
Antonio Vitiello, Francesco FerraraWiener klinische Wochenschrift : 2021
-
Antonio Vitiello, Francesco FerraraImmunologic Research : 2022
-
F. Ferrara, A. VitielloCardiovascular Toxicology : 2021
-
Antonio Vitiello, Francesco FerraraNaunyn-Schmiedeberg's Archives of Pharmacology : 2022
-
A. Vitiello, R. La Porta, V. D'Aiuto, F. FerraraHuman Immunology : 2021
-
Francesco Ferrara, Antonio VitielloNaunyn-Schmiedeberg's Archives of Pharmacology : 2021
-
Antonio Vitiello, Francesco FerraraMolecular Biology Reports : 2022
-
Francesco Ferrara, Andrea Zovi, Roberto Langella, Eduardo Nava, Ugo TramaJournal of Diabetes & Metabolic Disorders : 2023
-
Antonio Vitiello, Francesco FerraraRespiratory Medicine : 2021
-
Francesco Ferrara, Antonio VitielloWiener klinische Wochenschrift : 2021
-
Antonio Vitiello, Francesco FerraraThe Egyptian Heart Journal : 2021
-
Francesco Ferrara, Andrea Zovi, Marta Masi, Roberto Langella, Ugo Trama, Mariarosaria Boccellino, Antonio VitielloNaunyn-Schmiedeberg's Archives of Pharmacology : 2023
-
Antonio Vitiello, Francesco FerraraCurrent Research in Pharmacology and Drug Discovery : 2021
-
Antonio Vitiello, Andrea Zovi, Ugo Trama, Francesco FerraraHerz : 2023
-
Francesco Ferrara, Priscilla Santilli, Antonio Vitiello, Giampiero Forte, Vilma D’AiutoInternational Journal of Clinical Pharmacy : 2021